Good outcome of interstitial lung disease in patients with scleroderma associated to anti-PM/Scl antibody.

Objective: The objective of this article was to establish the clinical course of interstitial lung disease (ILD) in scleroderma related to the presence of anti-PM/Scl antibody compared with anti-Scl-70 in a Spanish cohort. Furthermore, no study has thoroughly investigated the outcome of pulmonary function test in the first group of patients.

Methods: A total of 63 Spanish patients with scleroderma and ILD were selected in a retrospective observational study.